Evidence map›Paper›PMID 31303767›Full record

ArticleOncoTargets and therapy2019

MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer.

Ke Liu, Xiao-Dong Jiao, Jie-Lu Hao, Bao-Dong Qin, Ying Wu, Wei Chen, Jun Liu, Xi He, Yuan-Sheng Zang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ke Liu *Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Xiao-Dong Jiao *Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Jie-Lu HaoDepartment of Nephrology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Bao-Dong QinDepartment of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Ying WuDepartment of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Wei ChenDepartment of Pharmacy, Changzheng Hospital, Naval Medical University Shanghai, People's Republic of China.
Jun LiuDepartment of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Xi HeDepartment of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Yuan-Sheng ZangDepartment of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Shanghai Changzheng Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AGS cellsGastric CancerMGc80-3 cellsMTSS1Tumor Suppressor

Identifiers

PMID31303767
PMCPMC6612291
OpenAlexW2953809744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.